Supplement for energy and focus: what works

Most products in this category are built around a marketing brief, not a clinical one. The ingredients with the strongest human evidence for cognitive energy and sustained attention are creatine, citicoline, L-theanine, and DHA, each with specific dose thresholds and forms that matter. One meta-analysis found creatine supplementation associated with meaningful working-memory effects in sleep-deprived adults. The rest of this piece is about what that evidence actually says, and what it demands of a formula.

The supplement for energy and focus that works is not the one with the longest ingredient list; it is the one where every ingredient matches the dose, form, and population the clinical evidence used.

From this read

What the evidence actually shows

I want to be direct about where the evidence sits. The human data for cognitive energy and focus supplements varies enormously in quality. Some ingredients have several well-controlled RCTs behind them. Others have mechanistic plausibility and a handful of small trials. A few are on labels almost entirely because they sound credible.

Creatine is the most surprising entry in this category for most people. It is associated in most minds with physical performance, and that association is fair: creatine increases physical performance in successive bursts of short-term, high-intensity exercise [GB-NHC]. But the cognitive data is genuinely interesting. Naderi et al. (2025) reviewed nutritional strategies affecting cognitive and physical performance, noting creatine's role in phosphocreatine resynthesis within neural tissue, particularly under conditions of metabolic stress such as sleep deprivation or sustained cognitive load. The brain accounts for roughly 20% of resting energy expenditure, and it draws on the same phosphocreatine system as muscle.

Citicoline (also called CDP-choline) is less well-known but has a reasonably consistent evidence base for attention. The mechanism is dual: it provides choline for acetylcholine synthesis and cytidine for uridine production, both relevant to membrane phospholipid turnover and neurotransmitter activity. The human trials are not enormous, and I would not overstate the certainty here, but the directional signal across studies is positive for processing speed and attentional accuracy at doses around 250 to 500 mg/day.

DHA is the one I feel most confident about at a foundational level. DHA contributes to the maintenance of normal brain function [GB-NHC] at a threshold of 250 mg/day. This is not a performance claim; it is a maintenance claim. But if you are chronically under-consuming omega-3s (and most people in the UK are), the cognitive substrate you are working with is compromised. Carretero-Krug et al. (2024) noted the widespread inadequacy of DHA intake across population groups, including adults not in special physiological states. The gap between what people consume and what the evidence supports is real.

---

The biology: what is actually happening in your brain

Energy and focus are not a single system. They involve at least three overlapping mechanisms, and a well-designed formula has to address more than one of them.

The first is cellular energy availability. Neurons are energetically expensive. They maintain steep ion gradients across their membranes continuously, which requires ATP. When ATP supply is constrained, firing rates drop, signal fidelity falls, and subjective fatigue rises. Creatine phosphate serves as a rapid ATP buffer: when a neuron fires rapidly, creatine phosphate donates a phosphate group to ADP to regenerate ATP faster than mitochondrial oxidative phosphorylation alone can manage. This is why creatine's cognitive effects are most pronounced under mental fatigue conditions rather than in well-rested, unstressed participants.

The second is cholinergic tone. Acetylcholine is the primary neurotransmitter for attention, working memory, and learning consolidation. Its synthesis depends on choline availability. Dietary choline intake is insufficient for most people. Citicoline may provide a bioavailable choline source, and the cytidine component converts to uridine in circulation, which in turn may support synaptic membrane synthesis. Research is ongoing and large-scale confirmatory human trials are still limited, but the mechanistic rationale for citicoline is among the cleaner ones in this category.

The third is cortisol-mediated cognitive interference. Sustained stress narrows attentional bandwidth. It is not that you lack energy; it is that your threat-detection systems are consuming the cognitive resources that would otherwise go to focused work. Ashwagandha and Rhodiola rosea are both studied in the context of stress-related cognitive impairment. The human data on both is thinner than I would like, and I would be overstating it to call either definitively effective for focus in healthy, non-stressed adults. Research is ongoing and large-scale human trials remain limited. What the smaller trials do suggest is a reduction in perceived stress and fatigue, which is a plausible indirect pathway to better attentional performance.

If you want to go deeper on how L-theanine interacts with the attention system, particularly alongside caffeine, I have written about that specifically: l theanine and caffeine the combination worth understanding. The short version is that theanine at 200 mg may modulate alpha-wave activity in ways that support calm alertness, and the combination with caffeine has a better evidence base than either alone.

---

Dosing: what the clinical evidence actually requires

This is where most products fail, and where specification literacy matters most.

For creatine, the trials finding cognitive effects used 5 g daily of creatine monohydrate. Not 1 g. Not 500 mg buried in a blend. Five grams, taken consistently. A product that lists creatine at 500 mg is not delivering the thing that was tested. The form also matters: monohydrate is the form with the evidence base. Creatine HCl, creatine ethyl ester, and various branded alternatives have not matched the monohydrate trial record. Rōnin delivers 5, 000 mg of micronised creatine monohydrate per daily serving, which is the dose the evidence uses. Micronised powder means faster dissolution and better tolerability, not a different molecule.

For citicoline, the trials used 250 to 500 mg/day. At 250 mg, some studies show effects on attention and processing speed; at 500 mg, the signal is more consistent. A product listing "choline" generically (often as choline bitartrate) is not the same compound and has not been tested in the same way. The specific form matters. Rōnin uses 500 mg of citicoline as CDP-choline, which is the form used in the human trials, not a cheaper choline salt.

For DHA, the GB-NHC authorised threshold is 250 mg/day. Most fish oil capsules deliver somewhere between 120 and 300 mg of actual DHA per capsule, but the label often states total omega-3 or EPA+DHA combined, which obscures the DHA figure. The question to ask is: what is the DHA figure alone, and is it at least 250 mg? Rōnin delivers 650 mg of DHA from microencapsulated algal oil, which is both above the authorised threshold and free from the heavy-metal contamination risk associated with some fish-derived oils. DHA contributes to the maintenance of normal brain function [GB-NHC] at that threshold.

For L-theanine, the most-cited trials used 200 mg. That is the number on most credible labels, and it is what Rōnin delivers as crystalline L-theanine. Research on L-theanine for focus is ongoing and large-scale confirmatory RCTs are limited, but the dose-matching is at least consistent with what has been studied.

One honest constraint worth naming: Rhodiola rosea is included in Rōnin at 350 mg of root extract, which sits within the range used in smaller trials, but the evidence base is not as deep as for creatine or DHA. I include it because the directional signal on fatigue perception is consistent, not because the case is closed.

If you are also thinking about memory specifically, the evidence picture there overlaps but is not identical. I covered that in more detail in the memory supplement uk natural piece.

---

The label problem: why most products under-deliver

The supplement for energy and focus category has a structural problem. The ingredients that work at evidence-supported doses are expensive. Citicoline at 500 mg costs more per serving than most brands want to spend on a single ingredient. Creatine at 5 g adds meaningful weight to a capsule product (which is why most capsule-format nootropics either cap creatine at 500 mg or omit it entirely). Algal DHA at 650 mg is substantially pricier than a token fish oil inclusion.

So what happens? Brands include ten or twelve ingredients at doses that look credible on a label but are far below what the trials used. This is sometimes called "fairy dusting." The label reads like a clinical protocol. The doses are decorative.

The questions a sceptical buyer should ask are specific:

• Is the creatine dose stated in grams, not milligrams? If milligrams, is it 5, 000?
• Is the choline source listed as citicoline or CDP-choline specifically, or just "choline"?
• Is the DHA figure stated separately from total omega-3?
• Is the ashwagandha a named root extract (KSM-66 or Sensoril), or a generic leaf-and-root blend with no standardisation figure?
• Does the label state the extract form and the assay basis, or just the raw material weight?

Most products cannot answer all five. A product that can is either genuinely well-formulated or very good at appearing so, and the certificate of analysis will tell you which.

You can see how Rōnin approaches this at the KōJō Daily Formula page, where the full specification is listed ingredient by ingredient with form and dose stated explicitly.

---

Timing, consistency, and what "feeling it" actually means

One reason people abandon supplements for energy and focus is that they expect an acute effect and do not get one. Some ingredients do have acute effects: L-theanine at 200 mg may produce noticeable changes in subjective alertness within an hour. Citicoline may have some acute effects on attention. But creatine and DHA are not acute-effect ingredients. They work by raising baseline tissue concentrations over days and weeks.

Creatine takes approximately three to four weeks of daily supplementation at 5 g to reach full intramuscular and neural saturation without a loading phase. DHA takes longer still to shift tissue phospholipid composition meaningfully. If you take either for three days and feel nothing, that is not evidence of failure. It is evidence of how these molecules work.

This matters practically. The question is not "do I feel something today?" It is "is my cognitive substrate better supported at week six than it was at week zero?" That is a harder thing to measure subjectively, which is one reason the category gravitates toward stimulant-heavy formulas that produce an obvious short-term signal. The obvious signal is not always the useful one.

Sims et al. (2023) noted the importance of consistent nutritional strategy over time for performance outcomes, a principle that applies to cognitive performance as much as physical. Collins et al. (2021) similarly emphasised that nutritional periodisation and consistency underpin performance more reliably than any acute intervention. The cognitive supplement literature is less developed than the sports nutrition literature, but the same logic applies.

---

Ingredients with weaker evidence: honest about the gaps

Shilajit is included in some energy formulas, including Rōnin at 500 mg of purified extract. The mechanistic rationale involves fulvic acid and its proposed role in mitochondrial electron transport chain efficiency. The human data is thin and I would be overstating it to claim a well-established cognitive effect. Research is ongoing and large-scale human trials are limited. I include it at a dose consistent with the small trials that exist, not as a flagship claim.

Ubiquinol (the reduced form of CoQ10) is included at 100 mg in Rōnin. The rationale is mitochondrial: CoQ10 is a cofactor in the electron transport chain, and ubiquinol is the form that is more bioavailable than ubiquinone. The cognitive energy argument is indirect. Some evidence suggests ubiquinol may support mitochondrial function in older adults, but the direct cognitive trial data is limited and I would not anchor a focus claim on it. Research is ongoing.

Pine bark extract at 200 mg has some small-trial evidence for attention and working memory, partly attributed to its effects on nitric oxide production and cerebral blood flow. The trials are small and the effect sizes modest. Research is ongoing and large-scale confirmatory human trials are limited. It is a reasonable inclusion at the right dose, but not a cornerstone of the evidence case.

Glycine at 2, 000 mg is included primarily for its role in sleep quality, which has an indirect but real relevance to cognitive energy. Poor sleep is the most common cause of daytime cognitive fatigue. The glycine data for sleep onset and subjective sleep quality is more consistent than the direct cognitive data. Research is ongoing.

No supplement has been shown to fully replicate the cognitive recovery that a good night's sleep provides across a long day. That is not a reason to dismiss the category, but it is context worth keeping.

Incidentally, if you are interested in what sustained cognitive performance across extreme physical and environmental conditions looked like for early humans, the piece on The first people in Ireland walked from Wales. Here's what that journey actually looked like. is a different kind of read, but it puts modern concerns about focus and fatigue in a useful perspective.

---

Frequently asked questions

---

My honest take

I started building Rōnin because I kept buying products that listed the right ingredients and delivered the wrong doses. The citicoline would be 50 mg. The creatine would be 500 mg. The DHA would be lumped into a total omega-3 figure with no breakdown. It was not dishonesty exactly, more a category-wide habit of optimising for label impressiveness rather than clinical relevance.

What I am more uncertain about is the adaptogen stack. I believe in the mechanistic rationale for ashwagandha and Rhodiola rosea at the right doses and forms. The stress-fatigue pathway to cognitive performance is real. But I would not tell you the evidence is as solid as it is for creatine or DHA. It is not. I include them because the directional signal is consistent, the doses match what has been studied, and the safety data is good. That is a reasonable basis for inclusion. It is not the same as a well-powered RCT in healthy adults showing a statistically significant effect on a validated cognitive endpoint.

The thing I feel most strongly about is the DHA question. Most people in the UK are genuinely under-consuming it. If you eat oily fish regularly, you may not need to supplement. If you do not, the gap between your actual intake and the threshold for the authorised brain-function claim is likely meaningful. That is not a dramatic claim. It is just arithmetic.

The energy and focus category will keep growing. The marketing will keep outpacing the evidence. The way through that is not cynicism; it is specificity. Ask for the form. Ask for the dose. Ask whether it matches the trial. If a brand cannot answer those questions, the formula probably cannot either.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.

References (8 studies)

1. Naderi et al. (2025), Nutritional Strategies to Improve Post-exercise Recovery and Subsequent Exercise Performance: A Narrative Review. PMID 40221559.
2. Carretero-Krug et al. (2024), Nutritional Status of Breastfeeding Mothers and Impact of Diet and Dietary Supplementation: A Narrative Review. PMID 38276540.
3. Sims et al. (2023), International society of sports nutrition position stand: nutritional concerns of the female athlete. PMID 37221858.
4. Collins et al. (2021), UEFA expert group statement on nutrition in elite football. PMID 33097528.
5. Iraki et al. (2024), Nutrition Recommendations for Bodybuilders in the Off-Season: A Narrative Review. PMID 31247944.
6. Hector et al. (2018), Protein Recommendations for Weight Loss in Elite Athletes: A Focus on Body Composition and Performance. PMID 29182451.
7. Gaddey et al. (2021), Unintentional Weight Loss in Older Adults. PMID 34264616.
8. Blaak et al. (2021), Short chain fatty acids in human gut and metabolic health. PMID 32865024.